AI Article Synopsis
- The study explores the causal relationships between 486 blood metabolites and Graves' disease (GD) and Graves' ophthalmopathy (GO) using two-sample Mendelian randomization.
- Nine metabolites were linked to GD and thirteen to GO, both showing statistical significance.
- The findings suggest these metabolites and associated pathways could be valuable biomarkers for diagnosing and preventing GD and GO, as well as for investigating treatment options.
Article Abstract
Objectives: There is ample that metabolic dysregulation is involved in Graves' disease (GD) and Graves' ophthalmopathy (GO). Recent studies have identified numerous metabolites associated with GD and GO. However, the causal impact of metabolites on GD and GO remains to be investigated.
Methods: This two-sample Mendelian randomization (MR) analysis investigated the causal relationships between 486 blood metabolites and GD and GO. Sensitivity analysis was also performed to examine heterogeneity and pleiotropy.
Results: MR analysis showed that 9 and 13 metabolites were associated with GD and GO, respectively, each meeting the nominal significance criteria (inverse variance weighted, p < 0.05). Additionally, four metabolic pathways were identified for each condition using network-based MetaboAnalyst 5.0.
Conclusions: The metabolites and pathways discovered in this study could serve as circulating metabolic biomarkers for clinical screening and prevention of GD and GO. They can be also used for further studies on the mechanisms and drug targets in GD and GO.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s12020-024-03761-z | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!